Back to Lido Advisors, LLC Lido Advisors, LLC

RLMD

7 quarters

Position history for Lido Advisors, LLCLido Advisors, LLC's holdings in Relmada Therapeutics, Inc.

Yes. Lido Advisors holds 13,827 shares of RLMD (Relmada Therapeutics), worth $52,128, as of its Q3 2026 13F filing. It reduced the position by 78 shares (-0.6%) from Q2 2026. Lido Advisors has held RLMD since Q1 2025, across 7 quarterly 13F filings.

Current Value

$52,128

Current Shares

13,827

Total Value Change

+$48,374

Total Shares Change

-78

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
13,827
-0.6%
$52,1280.0%$3.77
0
2026-Q2
Unchanged
13,905
0.0%
$96,2230.0%$6.92
0
2026-Q1
Unchanged
13,905
0.0%
$96,7790.0%$6.96
0
2025-Q4
Unchanged
13,905
0.0%
$27,9490.0%$4.83
0
2025-Q3
Unchanged
13,905
0.0%
$27,9490.0%$2.01
0
2025-Q2
Unchanged
13,905
0.0%
$8,3470.0%$0.60
0
2025-Q1
New
13,905
-
$3,7540.0%$0.27
21

Other major holders of RLMD: RTW Investments, LP, Jupiter Topco LLC, Janus Henderson Group Ltd., RA Capital Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used